Feedback / Questions
Proellex-V (telapristone suppository) - Repros
Repros: BIO CEO & Investor Conference
(Repros)
-
Feb 12, 2014 -
Anticipated initiation of P2b trial for uterine fibroids in Q2 2014
Anticipated new P2b trial • Anticipated trial initiation date
•
Uterine Leiomyoma
http://www.veracast.com/bio/ceoinvestor2014/main/events/1395_repros/pdf/Repros_Therapeutics.pdf
Feb 12, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.